Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
N-acetyl cysteine (nac) has been identified as an interference source for certain assays involving trinder chemical pathways. beckman coulter initiated an investigation to determine if the interference would be observed in the dxc synchron products that utilize trinder reaction. the results from the study showed that cr-e and uric reagents are significantly affected by therapeutic levels of n-acetyl cysteine. nac is currently not listed as an interferent in the chemistry information sheets for cr-e or for uric which may lead to false low results for cr-e and uric to be generated.